Back to Posters

Comparing actionable results for breast and colorectal cancer patients across multigene panels.

Date:

Friday, Jun 2, 2017 12:00pm – 1:00am

Conference:

Authors:

Carin Espenschied, Dr. Robina Smith, Holly Laduca, Jessica Profato, Kelly Fulk, Patrick Reineke

For both breast cancer and colorectal cancer patients, the utilization of a multi-gene panel with more genes led to more positive results than a multi-gene panel with fewer genes, and the vast majority of additional findings occur in genes with published management guidelines.
These additional positive results can impact treatment decisions and cancer risk management, including earlier and/or more frequent screening,chemoprevention, and/or other measures.
In some cases, positive results occurred in genes not associated with the patient’s cancer diagnosis, but may still impact risk management for other cancer(s).